The expression and clinical significance of β-catenin and colorectal cancer stem cells marker EpCAMhigh/CD44+ in colorectal cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-12-19

AUTHORS

Dan Liu, Jinghua Sun, Jinming Zhu, Huan Zhou, Yang Zhang

ABSTRACT

ObjectiveThe aim of the study was to explore the role of Wnt/β-catenin signalling pathway in the maintenance, invasion and metastasis of colorectal cancer stem cells.MethodsDouble immunohistochemical staining was used to detect the expression of EpCAMhigh/CD44+ which is regarded as the marker of colorectal cancer stem cells in 80 cases of colorectal cancer and their corresponding liver metastases. The SP method of immunohistochemistry was used to detect the expression of the key protein β-catenin in the Wnt pathway in these tissue. The expression and correlation of β-catenin and EpCAMhigh/CD44+ in colorectal cancer were analyzed and their role on the biological behavior of colorectal cancer was explored.ResultsThe abnormal expression of β-catenin was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [55% (44/80) vs 10% (2/20), P < 0.05]. The positive expression of EpCAMhigh/CD44+ was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [66.25% (53/80) vs 0% (0/20), P < 0.05]. In the 80 cases of colorectal cancer, the abnormal expression of β-catenin has no correlation with gender (P = 0.079), age (P = 0.416) and the magnitude (P = 0.816) of the tumor (P > 0.05), but it was significantly correlated with degree of differentiation (P = 0.001), depth of invasion (P = 0.001), clinical stage (P = 0.000) and metastasis (P = 0.000). In the colorectal cancer, the expression of EpCAMhigh/CD44+ cells has no correlation with gender (P = 0.934) and the magnitude (P = 0.160) of the tumor (P > 0.05), but was significantly correlated with age (P = 0.021), degree of differentiation (P = 0.013), depth of invasion (P = 0.000), clinical stage (P = 0.000) and metastasis (P = 0.000). In the corresponding liver metastases, we could also detecte EpCAMhigh/CD44+ cells. In cases with abnormal expression of β-catenin, the positive expression rate of EpCAMhigh/CD44+ was significantly higher than those with normal expression of β-catenin (84.1% vs 44.4%), and the difference was statistically significant (P < 0.05).ConclusionThe abnormal activation of Wnt/β-catenin signalling pathway may prompt the abnormal proliferation of the colorectal cancer stem cells, which leads to the recurrence and metastasis of the cancer. More... »

PAGES

581-585

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10330-013-1258-z

DOI

http://dx.doi.org/10.1007/s10330-013-1258-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016059508


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China", 
          "id": "http://www.grid.ac/institutes/grid.452828.1", 
          "name": [
            "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Dan", 
        "id": "sg:person.011744741431.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011744741431.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China", 
          "id": "http://www.grid.ac/institutes/grid.452828.1", 
          "name": [
            "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sun", 
        "givenName": "Jinghua", 
        "id": "sg:person.01017162355.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017162355.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The Affiliated Zhongshan Hospital of DaLian University, 116001, DaLian, China", 
          "id": "http://www.grid.ac/institutes/grid.459353.d", 
          "name": [
            "Department of Oncology, The Affiliated Zhongshan Hospital of DaLian University, 116001, DaLian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Jinming", 
        "id": "sg:person.013337702431.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013337702431.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China", 
          "id": "http://www.grid.ac/institutes/grid.452828.1", 
          "name": [
            "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Huan", 
        "id": "sg:person.014135263031.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014135263031.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China", 
          "id": "http://www.grid.ac/institutes/grid.452828.1", 
          "name": [
            "Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Yang", 
        "id": "sg:person.01056613304.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056613304.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10330-008-0074-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026153382", 
          "https://doi.org/10.1007/s10330-008-0074-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-012-0284-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037747757", 
          "https://doi.org/10.1007/s12032-012-0284-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1519-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048746390", 
          "https://doi.org/10.1245/s10434-010-1519-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-007-9695-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019444851", 
          "https://doi.org/10.1245/s10434-007-9695-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-9-212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002613769", 
          "https://doi.org/10.1186/1476-4598-9-212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1746-1596-7-115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014484884", 
          "https://doi.org/10.1186/1746-1596-7-115"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12-19", 
    "datePublishedReg": "2013-12-19", 
    "description": "ObjectiveThe aim of the study was to explore the role of Wnt/\u03b2-catenin signalling pathway in the maintenance, invasion and metastasis of colorectal cancer stem cells.MethodsDouble immunohistochemical staining was used to detect the expression of EpCAMhigh/CD44+ which is regarded as the marker of colorectal cancer stem cells in 80 cases of colorectal cancer and their corresponding liver metastases. The SP method of immunohistochemistry was used to detect the expression of the key protein \u03b2-catenin in the Wnt pathway in these tissue. The expression and correlation of \u03b2-catenin and EpCAMhigh/CD44+ in colorectal cancer were analyzed and their role on the biological behavior of colorectal cancer was explored.ResultsThe abnormal expression of \u03b2-catenin was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [55% (44/80) vs 10% (2/20), P < 0.05]. The positive expression of EpCAMhigh/CD44+ was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [66.25% (53/80) vs 0% (0/20), P < 0.05]. In the 80 cases of colorectal cancer, the abnormal expression of \u03b2-catenin has no correlation with gender (P = 0.079), age (P = 0.416) and the magnitude (P = 0.816) of the tumor (P > 0.05), but it was significantly correlated with degree of differentiation (P = 0.001), depth of invasion (P = 0.001), clinical stage (P = 0.000) and metastasis (P = 0.000). In the colorectal cancer, the expression of EpCAMhigh/CD44+ cells has no correlation with gender (P = 0.934) and the magnitude (P = 0.160) of the tumor (P > 0.05), but was significantly correlated with age (P = 0.021), degree of differentiation (P = 0.013), depth of invasion (P = 0.000), clinical stage (P = 0.000) and metastasis (P = 0.000). In the corresponding liver metastases, we could also detecte EpCAMhigh/CD44+ cells. In cases with abnormal expression of \u03b2-catenin, the positive expression rate of EpCAMhigh/CD44+ was significantly higher than those with normal expression of \u03b2-catenin (84.1% vs 44.4%), and the difference was statistically significant (P < 0.05).ConclusionThe abnormal activation of Wnt/\u03b2-catenin signalling pathway may prompt the abnormal proliferation of the colorectal cancer stem cells, which leads to the recurrence and metastasis of the cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10330-013-1258-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1032171", 
        "issn": [
          "2095-9621", 
          "1613-9089"
        ], 
        "name": "The Chinese-German Journal of Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "colorectal cancer stem cells", 
      "cancer stem cells", 
      "colorectal cancer", 
      "corresponding liver metastases", 
      "normal intestinal mucosa", 
      "depth of invasion", 
      "Wnt/\u03b2", 
      "liver metastases", 
      "clinical stage", 
      "abnormal expression", 
      "degree of differentiation", 
      "intestinal mucosa", 
      "stem cells", 
      "positive expression rate", 
      "clinical significance", 
      "immunohistochemical staining", 
      "abnormal proliferation", 
      "metastasis", 
      "abnormal activation", 
      "positive expression", 
      "cancer", 
      "CD44", 
      "biological behavior", 
      "expression rate", 
      "mucosa", 
      "Wnt pathway", 
      "tumors", 
      "catenin", 
      "normal expression", 
      "invasion", 
      "age", 
      "cells", 
      "expression", 
      "pathway", 
      "gender", 
      "protein \u03b2", 
      "recurrence", 
      "immunohistochemistry", 
      "cases", 
      "differentiation", 
      "staining", 
      "correlation", 
      "role", 
      "proliferation", 
      "markers", 
      "tissue", 
      "activation", 
      "aim", 
      "stage", 
      "significance", 
      "differences", 
      "study", 
      "degree", 
      "rate", 
      "maintenance", 
      "SP method", 
      "magnitude", 
      "method", 
      "behavior", 
      "depth", 
      "MethodsDouble immunohistochemical staining", 
      "EpCAMhigh/CD44", 
      "key protein \u03b2", 
      "paraneoplastic normal intestinal mucosa", 
      "colorectal cancer stem cells marker EpCAMhigh/CD44", 
      "cancer stem cells marker EpCAMhigh/CD44", 
      "stem cells marker EpCAMhigh/CD44", 
      "cells marker EpCAMhigh/CD44"
    ], 
    "name": "The expression and clinical significance of \u03b2-catenin and colorectal cancer stem cells marker EpCAMhigh/CD44+ in colorectal cancer", 
    "pagination": "581-585", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016059508"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10330-013-1258-z"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10330-013-1258-z", 
      "https://app.dimensions.ai/details/publication/pub.1016059508"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10330-013-1258-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1258-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1258-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1258-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1258-z'


 

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      22 PREDICATES      99 URIs      85 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10330-013-1258-z schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nce91f1a2fef54519a24113edbaaca7b2
4 schema:citation sg:pub.10.1007/s10330-008-0074-3
5 sg:pub.10.1007/s12032-012-0284-y
6 sg:pub.10.1186/1476-4598-9-212
7 sg:pub.10.1186/1746-1596-7-115
8 sg:pub.10.1245/s10434-007-9695-y
9 sg:pub.10.1245/s10434-010-1519-9
10 schema:datePublished 2013-12-19
11 schema:datePublishedReg 2013-12-19
12 schema:description ObjectiveThe aim of the study was to explore the role of Wnt/β-catenin signalling pathway in the maintenance, invasion and metastasis of colorectal cancer stem cells.MethodsDouble immunohistochemical staining was used to detect the expression of EpCAMhigh/CD44+ which is regarded as the marker of colorectal cancer stem cells in 80 cases of colorectal cancer and their corresponding liver metastases. The SP method of immunohistochemistry was used to detect the expression of the key protein β-catenin in the Wnt pathway in these tissue. The expression and correlation of β-catenin and EpCAMhigh/CD44+ in colorectal cancer were analyzed and their role on the biological behavior of colorectal cancer was explored.ResultsThe abnormal expression of β-catenin was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [55% (44/80) vs 10% (2/20), P < 0.05]. The positive expression of EpCAMhigh/CD44+ was significantly higher in colorectal cancer than in the paraneoplastic normal intestinal mucosa [66.25% (53/80) vs 0% (0/20), P < 0.05]. In the 80 cases of colorectal cancer, the abnormal expression of β-catenin has no correlation with gender (P = 0.079), age (P = 0.416) and the magnitude (P = 0.816) of the tumor (P > 0.05), but it was significantly correlated with degree of differentiation (P = 0.001), depth of invasion (P = 0.001), clinical stage (P = 0.000) and metastasis (P = 0.000). In the colorectal cancer, the expression of EpCAMhigh/CD44+ cells has no correlation with gender (P = 0.934) and the magnitude (P = 0.160) of the tumor (P > 0.05), but was significantly correlated with age (P = 0.021), degree of differentiation (P = 0.013), depth of invasion (P = 0.000), clinical stage (P = 0.000) and metastasis (P = 0.000). In the corresponding liver metastases, we could also detecte EpCAMhigh/CD44+ cells. In cases with abnormal expression of β-catenin, the positive expression rate of EpCAMhigh/CD44+ was significantly higher than those with normal expression of β-catenin (84.1% vs 44.4%), and the difference was statistically significant (P < 0.05).ConclusionThe abnormal activation of Wnt/β-catenin signalling pathway may prompt the abnormal proliferation of the colorectal cancer stem cells, which leads to the recurrence and metastasis of the cancer.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf Na3355d4b255246f597df6959188bf788
17 Nebef2fc997d841bab0c64a2d56c3c777
18 sg:journal.1032171
19 schema:keywords CD44
20 EpCAMhigh/CD44
21 MethodsDouble immunohistochemical staining
22 SP method
23 Wnt pathway
24 Wnt/β
25 abnormal activation
26 abnormal expression
27 abnormal proliferation
28 activation
29 age
30 aim
31 behavior
32 biological behavior
33 cancer
34 cancer stem cells
35 cancer stem cells marker EpCAMhigh/CD44
36 cases
37 catenin
38 cells
39 cells marker EpCAMhigh/CD44
40 clinical significance
41 clinical stage
42 colorectal cancer
43 colorectal cancer stem cells
44 colorectal cancer stem cells marker EpCAMhigh/CD44
45 correlation
46 corresponding liver metastases
47 degree
48 degree of differentiation
49 depth
50 depth of invasion
51 differences
52 differentiation
53 expression
54 expression rate
55 gender
56 immunohistochemical staining
57 immunohistochemistry
58 intestinal mucosa
59 invasion
60 key protein β
61 liver metastases
62 magnitude
63 maintenance
64 markers
65 metastasis
66 method
67 mucosa
68 normal expression
69 normal intestinal mucosa
70 paraneoplastic normal intestinal mucosa
71 pathway
72 positive expression
73 positive expression rate
74 proliferation
75 protein β
76 rate
77 recurrence
78 role
79 significance
80 stage
81 staining
82 stem cells
83 stem cells marker EpCAMhigh/CD44
84 study
85 tissue
86 tumors
87 schema:name The expression and clinical significance of β-catenin and colorectal cancer stem cells marker EpCAMhigh/CD44+ in colorectal cancer
88 schema:pagination 581-585
89 schema:productId N54b8d879492d40b3afd71304cdc24b07
90 Ne80ed1abf2ce4a839daa01d81436fc19
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016059508
92 https://doi.org/10.1007/s10330-013-1258-z
93 schema:sdDatePublished 2022-01-01T18:30
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N6c2e32a82bc94eefb48fa56dcad49939
96 schema:url https://doi.org/10.1007/s10330-013-1258-z
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N0d32542261714fada79caf8e7aa84657 rdf:first sg:person.014135263031.20
101 rdf:rest N2b72148dc94d4652b64798ff2f428371
102 N2b72148dc94d4652b64798ff2f428371 rdf:first sg:person.01056613304.46
103 rdf:rest rdf:nil
104 N54b8d879492d40b3afd71304cdc24b07 schema:name dimensions_id
105 schema:value pub.1016059508
106 rdf:type schema:PropertyValue
107 N6c2e32a82bc94eefb48fa56dcad49939 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 Na3355d4b255246f597df6959188bf788 schema:issueNumber 12
110 rdf:type schema:PublicationIssue
111 Nce91f1a2fef54519a24113edbaaca7b2 rdf:first sg:person.011744741431.14
112 rdf:rest Nfd169be49ee1493fb799023a93ab6581
113 Ne80ed1abf2ce4a839daa01d81436fc19 schema:name doi
114 schema:value 10.1007/s10330-013-1258-z
115 rdf:type schema:PropertyValue
116 Nebef2fc997d841bab0c64a2d56c3c777 schema:volumeNumber 12
117 rdf:type schema:PublicationVolume
118 Nf1fbed9c6d204e8e87499a2af86b47b4 rdf:first sg:person.013337702431.11
119 rdf:rest N0d32542261714fada79caf8e7aa84657
120 Nfd169be49ee1493fb799023a93ab6581 rdf:first sg:person.01017162355.66
121 rdf:rest Nf1fbed9c6d204e8e87499a2af86b47b4
122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
123 schema:name Medical and Health Sciences
124 rdf:type schema:DefinedTerm
125 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
126 schema:name Oncology and Carcinogenesis
127 rdf:type schema:DefinedTerm
128 sg:journal.1032171 schema:issn 1613-9089
129 2095-9621
130 schema:name The Chinese-German Journal of Clinical Oncology
131 schema:publisher Springer Nature
132 rdf:type schema:Periodical
133 sg:person.01017162355.66 schema:affiliation grid-institutes:grid.452828.1
134 schema:familyName Sun
135 schema:givenName Jinghua
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017162355.66
137 rdf:type schema:Person
138 sg:person.01056613304.46 schema:affiliation grid-institutes:grid.452828.1
139 schema:familyName Zhang
140 schema:givenName Yang
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056613304.46
142 rdf:type schema:Person
143 sg:person.011744741431.14 schema:affiliation grid-institutes:grid.452828.1
144 schema:familyName Liu
145 schema:givenName Dan
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011744741431.14
147 rdf:type schema:Person
148 sg:person.013337702431.11 schema:affiliation grid-institutes:grid.459353.d
149 schema:familyName Zhu
150 schema:givenName Jinming
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013337702431.11
152 rdf:type schema:Person
153 sg:person.014135263031.20 schema:affiliation grid-institutes:grid.452828.1
154 schema:familyName Zhou
155 schema:givenName Huan
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014135263031.20
157 rdf:type schema:Person
158 sg:pub.10.1007/s10330-008-0074-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026153382
159 https://doi.org/10.1007/s10330-008-0074-3
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/s12032-012-0284-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1037747757
162 https://doi.org/10.1007/s12032-012-0284-y
163 rdf:type schema:CreativeWork
164 sg:pub.10.1186/1476-4598-9-212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002613769
165 https://doi.org/10.1186/1476-4598-9-212
166 rdf:type schema:CreativeWork
167 sg:pub.10.1186/1746-1596-7-115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014484884
168 https://doi.org/10.1186/1746-1596-7-115
169 rdf:type schema:CreativeWork
170 sg:pub.10.1245/s10434-007-9695-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1019444851
171 https://doi.org/10.1245/s10434-007-9695-y
172 rdf:type schema:CreativeWork
173 sg:pub.10.1245/s10434-010-1519-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048746390
174 https://doi.org/10.1245/s10434-010-1519-9
175 rdf:type schema:CreativeWork
176 grid-institutes:grid.452828.1 schema:alternateName Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China
177 schema:name Department of Oncology, The Second Affiliated Hospital of DaLian Medical University, 116027, DaLian, China
178 rdf:type schema:Organization
179 grid-institutes:grid.459353.d schema:alternateName Department of Oncology, The Affiliated Zhongshan Hospital of DaLian University, 116001, DaLian, China
180 schema:name Department of Oncology, The Affiliated Zhongshan Hospital of DaLian University, 116001, DaLian, China
181 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...